NEUROGASTRX INC has a total of 17 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Japan and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are BETHESDA PHARMACEUTICALS INC, MANLEY PAUL W and NERRE THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Japan | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | De Colle Cyril | 13 |
#2 | Pasricha Pankaj | 13 |
#3 | Pankaj Pasricha | 3 |
#4 | Cyril De Colle | 3 |
#5 | Wustrow David | 2 |
#6 | Yu Shu | 1 |
Publication | Filing date | Title |
---|---|---|
US10836757B1 | Polymorphic forms of metopimazine | |
WO2015200369A1 | Prodrugs of metopimazine | |
BR112015015258A2 | Methods to Treat Gastrointestinal Tract Disorders |